Sean Muthian

Vice President, Chief Technology & Strategy Officer Cytiva

Seminars

Wednesday 5th November 2025
Laying Out Advances in ADC Development & Manufacturing
8:30 am
  • Discussing tools used for the efficient and scalable manufacturing of the mAb intermediate, which serves as a key starting point for ADC conjugation
  • Overcoming ADC mAb diversity challenges via AI-driven cell line design
  • Explaining operator safety risk-mitigation enabled by agnostic, automated solutions
Sean Muthian